ArticleCureus2026

Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol.

Simon B Bactawar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.